(1) As used in this chapter, unless the context otherwise requires:(1) “Board” means the board of pharmacy created by § 63-10-301;(2) “Commissioner” means the commissioner of health;(3) “Controlled substance analogues” is defined as in § 39-17-454;(4) “Controlled substances” is defined as in § 39-17-402;(5) “Director” means the director of the board of pharmacy elected pursuant to § 63-10-303;(6) “Legend drugs” is defined as in § 53-10-101; and(7) “Person” means an individual, corporation, government or governmental subdivision or agency, business trust, estate, trust, partnership or association, or any other legal entity.
(1) “Board” means the board of pharmacy created by § 63-10-301;
(2) “Commissioner” means the commissioner of health;
(3) “Controlled substance analogues” is defined as in § 39-17-454;
(4) “Controlled substances” is defined as in § 39-17-402;
(5) “Director” means the director of the board of pharmacy elected pursuant to § 63-10-303;
(6) “Legend drugs” is defined as in § 53-10-101; and
(7) “Person” means an individual, corporation, government or governmental subdivision or agency, business trust, estate, trust, partnership or association, or any other legal entity.